Function Health Pricing Analysis & Total Cost: Is It Worth It in 2025?

What Function Health Actually Costs

Function Health's pricing is straightforward on the surface. The membership is $499 per year. That single annual fee covers two blood draws, a panel of roughly 100 biomarkers per draw, and access to a physician-reviewed dashboard that flags abnormal results and provides context.

There are no per-test fees added on top of the membership, no copays for the interpretation layer, and no separate charge for the mobile app. The $499 is the all-in number for the core service.

What the $499 Does and Does Not Include

The membership covers:

• Two comprehensive phlebotomy appointments at affiliated draw sites
• A biomarker panel that spans cardiometabolic risk, hormones, thyroid function, liver and kidney function, complete blood count, inflammatory markers (including high-sensitivity C-reactive protein and homocysteine), cancer screening markers (PSA, CA-125, AFP), micronutrients (ferritin, vitamin D 25-OH, B12, magnesium), and metabolic hormones (insulin, IGF-1, DHEA-S, testosterone)
• Physician review flagging results outside reference ranges
• In-app trend tracking across draws

The membership does not include prescription medications. If a physician reviewing your panel recommends a prescription (for example, levothyroxine for subclinical hypothyroidism, or metformin for pre-diabetes), that prescription is fulfilled separately through a pharmacy and billed to you or your insurer independently.

Hidden Costs to Budget For

The $499 sticker price can expand in practice. Patients who act on findings may incur:

• Specialist referral costs if Function's physicians escalate a finding (e.g., a high PSA triggering a urology consult billed through traditional insurance)
• Prescription drug costs outside the membership
• Follow-up confirmatory testing if a single borderline marker needs repeat measurement before a diagnosis

The company does not charge for additional physician messaging within the platform, which limits one common hidden-cost category found in many telehealth models.

How Function Health Compares to Alternatives

Function Health's $499 annual price sits in the mid-range of the direct-to-consumer (DTC) lab market, but comparing sticker prices alone misses the structural differences between models. Labcorp OnDemand, Quest Diagnostics, and specialty longevity platforms each have different cost architectures.

Building a Comparable Panel Through Labcorp OnDemand or Quest

Replicating a 100-biomarker panel through Labcorp OnDemand or Quest MyQuest on a pay-per-test basis is expensive. A sampling of retail prices from Labcorp OnDemand in 2024 illustrates the gap:

• Comprehensive metabolic panel: $29, $49
• Lipid panel with direct LDL: $29, $59
• Complete blood count with differential: $29, $49
• TSH plus free T3 and free T4: $59, $99
• Testosterone total and free: $79, $129
• High-sensitivity CRP: $29, $49
• Hemoglobin A1c: $29, $49
• Vitamin D 25-OH: $49, $79
• Ferritin: $29, $49
• Homocysteine: $49, $79
• PSA: $39, $69
• Insulin fasting: $39, $69
• IGF-1: $79, $129

Adding those 13 panels alone reaches $577 to $927 for a single draw. Function Health runs two draws per year. The math favors the subscription model for anyone who would otherwise order this volume of testing out-of-pocket. Research published in JAMA Internal Medicine confirms that out-of-pocket laboratory costs are a significant barrier to preventive testing for uninsured and underinsured adults, with some patients deferring testing due to cost. [1]

Marek Health: A Direct Competitor

Marek Health positions itself as a closer competitor. Marek charges $99 per month ($1,188 per year) for its top-tier membership, which includes quarterly draws and physician management of hormone protocols. For patients who want active TRT, HRT, or thyroid management with ongoing dose adjustments, Marek's model may provide more clinical depth. For patients who simply want annual surveillance data without active prescription management, Function Health's $499 is substantially cheaper.

InsideTracker

InsideTracker sells individual panel packages rather than annual memberships. Its Ultimate plan, which includes 43 biomarkers, costs $699 per single draw. Two draws per year at that price would cost $1,398. Function Health's broader panel at $499 beats InsideTracker on both cost per biomarker and total annual spend.

Insurance-Based Preventive Panels

Under the Affordable Care Act, certain preventive laboratory services are covered at no cost to the patient when ordered by a network physician. The U.S. Preventive Services Task Force (USPSTF) recommends lipid screening, blood glucose screening, and blood pressure measurement for adults at certain risk thresholds. [2] These covered tests overlap with a subset of Function Health's panel. Patients with comprehensive insurance and an engaged primary care physician can obtain some of Function's value at zero out-of-pocket cost. The gaps tend to appear in the hormone, micronutrient, and specialty cancer-marker categories, which are not broadly covered as routine preventive services.

Is Function Health Clinically Legitimate?

Function Health operates within a licensed physician oversight model. The company contracts with board-certified physicians who review results and provide clinical context. This is not a wellness app generating algorithmic recommendations without a licensed provider in the chain.

The Evidence Base for Comprehensive Metabolic Surveillance

The core premise of a broad annual biomarker panel rests on whether early identification of metabolic abnormalities leads to clinical intervention and improved outcomes. The evidence here is mixed but directionally supportive for several specific markers.

A 2022 analysis published in The Lancet found that undiagnosed type 2 diabetes affects an estimated 6.1 million adults in the United States, many of whom could be identified through routine fasting glucose and HbA1c testing. [3] Function Health's panel includes both fasting insulin and HbA1c, providing a more complete picture of insulin resistance than HbA1c alone. The HOMA-IR calculation derived from fasting insulin and glucose is increasingly recognized as a useful pre-diagnostic tool. Research in Diabetes Care demonstrates that elevated fasting insulin predicts incident type 2 diabetes independently of HbA1c in populations that still have normal glycemia. [4]

For cardiovascular risk, the 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease acknowledges that high-sensitivity CRP and coronary artery calcium scoring add discriminatory value to traditional Framingham risk estimation. [5] Function Health includes hs-CRP in its standard panel. Apolipoprotein B (ApoB), a more accurate predictor of LDL particle-driven atherosclerosis than calculated LDL-C, is also included. A 2021 meta-analysis in the European Heart Journal (N=20 studies, 237,000 participants) found ApoB superior to LDL-C for predicting major adverse cardiovascular events in statin-treated patients. [6]

Hormone Panels and Evidence-Based Thresholds

Function Health includes testosterone, estradiol, DHEA-S, SHBG, and IGF-1 in its standard panel. This is broader than most annual physicals. The clinical question is whether measuring these values in asymptomatic adults drives meaningful intervention.

The Endocrine Society's clinical practice guideline on testosterone therapy in men recommends against routine screening of asymptomatic men for testosterone deficiency, preferring testing in men with signs or symptoms consistent with hypogonadism. [7] This creates a legitimate tension with Function Health's approach. The counterargument is that low testosterone is often subclinical or attributed to general fatigue before a formal diagnosis is considered. Identifying a testosterone level of 220 ng/dL in a 42-year-old man reporting fatigue and reduced libido could initiate a workup that a standard physical would not trigger if the physician did not order the test.

Cancer Marker Caveats

Function includes PSA, CA-125, AFP, and CEA. These markers carry false-positive rates that can generate patient anxiety and unnecessary downstream procedures. The USPSTF gives PSA screening a Grade C recommendation for men aged 55 to 69, meaning the decision should be individualized. [8] CA-125 is not recommended by USPSTF as a general ovarian cancer screening tool in average-risk women due to poor specificity. [9] Function Health's physician review layer theoretically contextualizes these caveats, but patients should understand that a flagged CA-125 may lead to an imaging workup that costs more than the annual membership.

The Value Question: Who Actually Benefits

Not every patient gets equivalent value from a $499 comprehensive lab panel. The framework below organizes the likely benefit tiers:

Tier 1: High value (patient profile) Adults aged 35 to 65 without primary care access or with a primary care physician who does not routinely order metabolic or hormone panels. Individuals with a family history of cardiovascular disease, diabetes, or thyroid disease. Patients who have already been told by a physician that certain markers are "borderline" and want proactive surveillance. People managing weight, energy, or performance who want data beyond standard annual bloodwork.

Tier 2: Moderate value Adults with comprehensive insurance and an engaged primary care physician who orders broad metabolic panels annually. In this scenario, Function Health adds value mainly in the hormone, micronutrient, and specialty cancer-marker categories not routinely covered.

Tier 3: Lower value Adults under 30 with no family history of metabolic or cardiovascular disease and no symptoms. The pre-test probability of finding actionable abnormalities in this group is low, and the base rate of false positives can exceed true positives for several markers in this demographic.

What the Reviews Say (and What They Miss)

User reviews of Function Health cluster around a few consistent themes. Positive reviews frequently cite finding previously undetected vitamin D deficiency, thyroid abnormalities (particularly subclinical hypothyroidism with TSH between 4.5 and 10 mIU/L), and insulin resistance patterns that prompted lifestyle changes. Negative reviews cite the waiting-list experience (largely resolved as of 2024), the absence of real-time physician chat, and frustration that the platform identifies problems without always providing a direct treatment path within the membership.

One consistent criticism is that Function Health's physician oversight model is review-based, not interactive. A physician reviews your panel and flags abnormalities, but a scheduled telehealth consultation is not included in the base $499 membership. For patients who want to discuss findings in real time, that gap matters.

Function Health and GLP-1 / Hormone Therapy Integration

Function Health does not directly prescribe GLP-1 receptor agonists (semaglutide, tirzepatide) or testosterone replacement as part of its core membership. The platform's physician oversight is structured for laboratory review, not ongoing drug management. However, the biomarker data Function generates is directly relevant to GLP-1 or TRT candidacy assessment.

Lab Data Relevant to GLP-1 Candidacy

The FDA's prescribing information for semaglutide 2.4 mg (Wegovy) specifies a BMI threshold of 30 kg/m2, or 27 kg/m2 with at least one weight-related comorbidity. [10] Function Health's panel includes HbA1c, fasting insulin, and lipid markers that document those comorbidities. A patient who brings Function Health data to a GLP-1 prescriber arrives with a richer metabolic picture than a patient who only has a recent basic metabolic panel.

In STEP-1 (N=1,961), semaglutide 2.4 mg produced 14.9% mean body weight loss at 68 weeks versus 2.4% with placebo (P<0.001). [11] Patients who are candidates for semaglutide based on metabolic markers could use Function Health data to document eligibility and then seek a separate GLP-1 prescriber, such as a HealthRX provider.

Lab Data Relevant to TRT Candidacy

The Endocrine Society defines biochemical hypogonadism in men as a morning serum testosterone below 300 ng/dL on two separate measurements. [7] Function Health measures total testosterone and SHBG, from which free testosterone can be estimated. Two consecutive Function Health draws showing testosterone below 300 ng/dL, combined with consistent symptoms, satisfy the Endocrine Society's testing criteria for initiating a hypogonadism workup. This is one of the clearest clinical use cases for the membership.

Billing, FSA/HSA, and Tax Considerations

Function Health's $499 membership fee is not covered by health insurance. The company explicitly states this on its website. The membership may qualify as a reimbursable expense through a Flexible Spending Account (FSA) or Health Savings Account (HSA), but this requires a Letter of Medical Necessity from a licensed physician. The IRS defines qualified medical expenses as costs for the diagnosis, cure, mitigation, treatment, or prevention of disease. Preventive laboratory testing for diagnostic purposes has been accepted by some FSA/HSA administrators as a qualified expense. Patients should confirm with their plan administrator before submitting a claim.

How to Evaluate Function Health Against Your Specific Situation

Before committing to the $499 annual membership, three questions narrow the decision:

First, what does your current insurance cover for preventive labs? Pull your last Explanation of Benefits or call your insurer to ask specifically about metabolic panels, thyroid panels, and hormone testing. If your insurer covers these annually with no patient cost-sharing, the marginal value of Function Health shrinks to its specialty markers.

Second, do you have an existing primary care relationship where you can discuss results? Function Health's physician review is not a substitute for a longitudinal primary care relationship. Patients who lack that relationship may find more clinical value from the data. Patients who already have an engaged physician may find the data redundant.

Third, what is your pre-test probability of actionable findings? A 58-year-old man with a family history of early coronary artery disease, borderline HbA1c of 5.8%, and untreated fatigue has a high pre-test probability of actionable findings across Function's panel. A 26-year-old woman in good health with no symptoms has a much lower probability.

For patients who decide to act on Function Health data and want a GLP-1, TRT, or hormone therapy prescription, that step requires a separate clinical relationship. HealthRX physicians review lab data, including Function Health panels, and can prescribe GLP-1 medications (semaglutide and tirzepatide), testosterone replacement therapy, and HRT based on documented biomarker findings. The minimum testosterone level that triggers a HealthRX prescribing evaluation is 300 ng/dL on two morning draws, consistent with Endocrine Society criteria. [7]